We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
67 hedge funds and large institutions have $13M invested in Atossa Therapeutics in 2025 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
172% more call options, than puts
Call options by funds: $166K | Put options by funds: $61K
122% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 9
40% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 10
2% more funds holding
Funds holding: 66 → 67 (+1)
0.13% more ownership
Funds ownership: 1% → 1.13% (+0.13%)
23% less capital invested
Capital invested by funds: $16.8M → $13M (-$3.84M)
Holders
67
Holders Change
+1
Holders Change %
+1.52%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
20
Reduced
9
Closed
10
Calls
$166K
Puts
$61K
Net Calls
+$105K
Net Calls Change
-$1K
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$359K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$269K |
| 3 |
Squarepoint
New York
|
-$220K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$73.8K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$55.5K |
